Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma

BACKGROUND AND OBJECTIVE: A quantitative tumor response evaluation to molecular-targeting agents in advanced renal cell carcinoma (RCC) is debatable. We aimed to evaluate the relationship between radiologic tumor response and pathological response in patients with advanced RCC who underwent presurgi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosogoe, Shogo, Hatakeyama, Shingo, Kusaka, Ayumu, Hamano, Itsuto, Tanaka, Yoshimi, Hagiwara, Kazuhisa, Hirai, Hideaki, Morohashi, Satoko, Kijima, Hiroshi, Yamamoto, Hayato, Tobisawa, Yuki, Yoneyama, Tohru, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Koie, Takuya, Ohyama, Chikara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564804/
https://www.ncbi.nlm.nih.gov/pubmed/28572534
http://dx.doi.org/10.18632/oncotarget.17930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564804/
https://www.ncbi.nlm.nih.gov/pubmed/28572534
http://dx.doi.org/10.18632/oncotarget.17930

Ejemplares similares